Elevated serum inhibin and tumor-associated trypsin inhibitor concentrations in a young woman with dysgerminoma of the ovary.
We describe a patient with dysgerminoma who had elevated serum inhibin, tumor-associated trypsin inhibitor (TATI), and CA 125 concentrations, which increased progressively during follow-up of the advancing disease. Inhibin levels correlated closely with disease behavior. In contrast to inhibin, serum TATI and CA 125 failed to reveal the presence of silent disease.
Santala
M
M
Department of Obstetrics and Gynecology, University Hospital of Oulu, Oulu, Finland. msantala@cc.oulu.fi
Burger
H
H
Ruokonen
A
A
Stenbäck
F
F
Kauppila
A
A
D000328:Adult; D004407:Dysgerminoma / Q000097:blood*; D005260:Female; D006801:Humans; D007265:Inhibins / Q000097:blood*; D010051:Ovarian Neoplasms / Q000097:blood*; D014359:Trypsin Inhibitor, Kazal Pancreatic / Q000097:blood*
D014359:Trypsin Inhibitor, Kazal Pancreatic; D007265:Inhibins